438 related articles for article (PubMed ID: 28970331)
1. Preclinical Evaluation of
Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
[TBL] [Abstract][Full Text] [Related]
2. Characterization of 3 Novel Tau Radiopharmaceuticals,
Wong DF; Comley RA; Kuwabara H; Rosenberg PB; Resnick SM; Ostrowitzki S; Vozzi C; Boess F; Oh E; Lyketsos CG; Honer M; Gobbi L; Klein G; George N; Gapasin L; Kitzmiller K; Roberts J; Sevigny J; Nandi A; Brasic J; Mishra C; Thambisetty M; Mogekar A; Mathur A; Albert M; Dannals RF; Borroni E
J Nucl Med; 2018 Dec; 59(12):1869-1876. PubMed ID: 29728519
[No Abstract] [Full Text] [Related]
3. Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer's Disease with Positron Emission Tomography.
Gobbi LC; Knust H; Körner M; Honer M; Czech C; Belli S; Muri D; Edelmann MR; Hartung T; Erbsmehl I; Grall-Ulsemer S; Koblet A; Rueher M; Steiner S; Ravert HT; Mathews WB; Holt DP; Kuwabara H; Valentine H; Dannals RF; Wong DF; Borroni E
J Med Chem; 2017 Sep; 60(17):7350-7370. PubMed ID: 28654263
[TBL] [Abstract][Full Text] [Related]
4. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y
J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Characterization of the Tau PET Tracer [
Harada R; Lerdsirisuk P; Shimizu Y; Yokoyama Y; Du Y; Kudo K; Ezura M; Ishikawa Y; Iwata R; Shidahara M; Ishiki A; Kikuchi A; Hatano Y; Ishihara T; Onodera O; Iwasaki Y; Yoshida M; Taki Y; Arai H; Kudo Y; Yanai K; Furumoto S; Okamura N
J Nucl Med; 2023 Sep; 64(9):1495-1501. PubMed ID: 37321821
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of
Kuwabara H; Comley RA; Borroni E; Honer M; Kitmiller K; Roberts J; Gapasin L; Mathur A; Klein G; Wong DF
J Nucl Med; 2018 Dec; 59(12):1877-1884. PubMed ID: 30097505
[TBL] [Abstract][Full Text] [Related]
7. [
Sanabria Bohórquez S; Marik J; Ogasawara A; Tinianow JN; Gill HS; Barret O; Tamagnan G; Alagille D; Ayalon G; Manser P; Bengtsson T; Ward M; Williams SP; Kerchner GA; Seibyl JP; Marek K; Weimer RM
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2077-2089. PubMed ID: 31254035
[TBL] [Abstract][Full Text] [Related]
8. Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351.
Oh M; Oh SJ; Lee SJ; Oh JS; Roh JH; Chung SJ; Lee JH; Lee CS; Kim JS
Clin Nucl Med; 2020 Nov; 45(11):841-847. PubMed ID: 32910050
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer.
Fodero-Tavoletti MT; Brockschnieder D; Villemagne VL; Martin L; Connor AR; Thiele A; Berndt M; McLean CA; Krause S; Rowe CC; Masters CL; Dinkelborg L; Dyrks T; Cappai R
Nucl Med Biol; 2012 Oct; 39(7):1042-8. PubMed ID: 22503458
[TBL] [Abstract][Full Text] [Related]
10. Discovery and preclinical characterization of [
Kroth H; Oden F; Molette J; Schieferstein H; Capotosti F; Mueller A; Berndt M; Schmitt-Willich H; Darmency V; Gabellieri E; Boudou C; Juergens T; Varisco Y; Vokali E; Hickman DT; Tamagnan G; Pfeifer A; Dinkelborg L; Muhs A; Stephens A
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2178-2189. PubMed ID: 31264169
[TBL] [Abstract][Full Text] [Related]
11. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β.
Brockschnieder D; Schmitt-Willich H; Heinrich T; Varrone A; Gulyás B; Toth M; Andersson J; Boemer U; Krause S; Friebe M; Dinkelborg L; Halldin C; Dyrks T
J Nucl Med; 2012 Nov; 53(11):1794-801. PubMed ID: 23008501
[TBL] [Abstract][Full Text] [Related]
12. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
Watanabe H
Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
[TBL] [Abstract][Full Text] [Related]
13. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.
Xia CF; Arteaga J; Chen G; Gangadharmath U; Gomez LF; Kasi D; Lam C; Liang Q; Liu C; Mocharla VP; Mu F; Sinha A; Su H; Szardenings AK; Walsh JC; Wang E; Yu C; Zhang W; Zhao T; Kolb HC
Alzheimers Dement; 2013 Nov; 9(6):666-76. PubMed ID: 23411393
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease.
Lerdsirisuk P; Harada R; Hayakawa Y; Shimizu Y; Ishikawa Y; Iwata R; Kudo Y; Okamura N; Furumoto S
Nucl Med Biol; 2021 Feb; 93():11-18. PubMed ID: 33221641
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles.
Hostetler ED; Walji AM; Zeng Z; Miller P; Bennacef I; Salinas C; Connolly B; Gantert L; Haley H; Holahan M; Purcell M; Riffel K; Lohith TG; Coleman P; Soriano A; Ogawa A; Xu S; Zhang X; Joshi E; Della Rocca J; Hesk D; Schenk DJ; Evelhoch JL
J Nucl Med; 2016 Oct; 57(10):1599-1606. PubMed ID: 27230925
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Evaluation of [(18)F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer.
Tago T; Furumoto S; Okamura N; Harada R; Adachi H; Ishikawa Y; Yanai K; Iwata R; Kudo Y
Mol Imaging Biol; 2016 Apr; 18(2):258-66. PubMed ID: 26194011
[TBL] [Abstract][Full Text] [Related]
17. Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807.
Declercq L; Celen S; Lecina J; Ahamed M; Tousseyn T; Moechars D; Alcazar J; Ariza M; Fierens K; Bottelbergs A; Mariën J; Vandenberghe R; Andres IJ; Van Laere K; Verbruggen A; Bormans G
Mol Imaging; 2016; 15():. PubMed ID: 27030397
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Evaluation of
Declercq L; Rombouts F; Koole M; Fierens K; Mariën J; Langlois X; Andrés JI; Schmidt M; Macdonald G; Moechars D; Vanduffel W; Tousseyn T; Vandenberghe R; Van Laere K; Verbruggen A; Bormans G
J Nucl Med; 2017 Jun; 58(6):975-981. PubMed ID: 28232614
[TBL] [Abstract][Full Text] [Related]
19. A highly selective and specific PET tracer for imaging of tau pathologies.
Zhang W; Arteaga J; Cashion DK; Chen G; Gangadharmath U; Gomez LF; Kasi D; Lam C; Liang Q; Liu C; Mocharla VP; Mu F; Sinha A; Szardenings AK; Wang E; Walsh JC; Xia C; Yu C; Zhao T; Kolb HC
J Alzheimers Dis; 2012; 31(3):601-12. PubMed ID: 22683529
[TBL] [Abstract][Full Text] [Related]
20. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.
Choi SR; Golding G; Zhuang Z; Zhang W; Lim N; Hefti F; Benedum TE; Kilbourn MR; Skovronsky D; Kung HF
J Nucl Med; 2009 Nov; 50(11):1887-94. PubMed ID: 19837759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]